GSA CAPITAL PARTNERS LLP
Position in KNSA — Kiniksa Pharmaceuticals International, plc
CIK 1362033
LONDON, X0
Position in KNSA
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$717,455
+$175,431 QoQ
Shares Held
11,219
-0.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#139
of 264 holders
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in KNSA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GSA CAPITAL PARTNERS LLP holds $11,914,926 across 21 Drug Manufacturers - Specialty & Generic names. KNSA ranks #6 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
55,201 | $2,264,897 | |
| 2 | ZTS |
Zoetis Inc.
|
18,470 | $1,327,254 | |
| 3 | IRWD |
Ironwood Pharmaceuticals Inc
|
259,512 | $1,092,545 | |
| 4 | BCRX |
Biocryst Pharmaceuticals Inc
|
90,210 | $902,100 | |
| 5 | LQDA |
Liquidia Corp
|
10,098 | $805,113 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
This page
|
11,219 | $717,455 | |
| 7 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
39,241 | $704,768 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
82,830 | $656,013 |
All Filings in KNSA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $717,455 | 11,219 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $542,024 | 11,257 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $2,846,002 | 68,994 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $3,028,118 | 77,984 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $564,966 | 20,418 | Shares | Sole | 2025-07-22 | |
| 2024-09-30 | $268,117 | 10,729 | Shares | Sole | 2024-11-05 | |
| No filing history on record for this holder in this stock. | ||||||